Japan Second Committee Approve Five New Drugs Including ICS/LABA Inhaler
This article was originally published in PharmAsia News
Executive Summary
MHLW Japan’s Second Committee on Drugs acknowledged the approval of five new drugs on July 26, including an ICS/LABA combination for bronchial asthma treatment from Kyorin.